Compare Heron Therapeutics Inc (HRTX) vs Virtu Financial Inc. Class A Common Stock (VIRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Virtu Financial Inc. Class A Common Stock — how do they compare? Heron Therapeutics Inc trades at $0.37 (market cap $68.01M), while Virtu Financial Inc. Class A Common Stock trades at $57.56 (market cap $5.10B). The key difference: Virtu Financial Inc. Class A Common Stock is far larger — about 75× Heron Therapeutics Inc's market cap, and Virtu Financial Inc. Class A Common Stock pays a 1.66% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Virtu Financial Inc. Class A Common Stock for 0 Days on average.
| HRTX | VIRT | |
|---|---|---|
Market Cap | $68.01M | $5.10B |
Volume | 1,891,941 | 871,626 |
Sector | Health | Financials |
52-Week High | $1.49 | $67.93 |
52-Week Low | $0.27 | $32.53 |
Typical Hold Time | 35 Days | 0 Days |
Enterprise Value | $174.75M | $14.81B |
Dividend Yield | — | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) is trading at $0.39, up 17.58% today, with a bullish technical outlook from moving averages but mixed signals from oscillators. The company maintains strong gross margins of 70.07% but continues to report net losses, with Q2 2026 missing both EPS and revenue expectations. Analyst sentiment remains overwhelmingly positive with 89% buy ratings despite recent earnings disappointments and negative profitability metrics.
While analyst consensus is strongly bullish, HRTX faces significant fundamental challenges including consistent net losses, negative ROE of -78.72%, and cash flow concerns. The stock's current momentum appears driven by technical factors rather than improving fundamentals, creating a high-risk investment profile that requires careful monitoring of upcoming Q3 earnings and revenue stabilization efforts.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Virtu Financial Inc. Class A Common Stock
Virtu Financial provides technology-enabled market-making and execution services. Its platforms help institutional, retail, and other market participants trade across global financial markets.
Read more on VIRT →
